Copaxone and Epinephrine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Copaxone (glatiramer acetate) and Epinephrine (epinephrine). Common drug interactions include cough among females and blood glucose increased among males.

The phase IV clinical study analyzes what interactions people have when they take Copaxone and Epinephrine. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Copaxone?

Copaxone has active ingredients of glatiramer acetate. It is often used in multiple sclerosis. eHealthMe is studying from 56,931 Copaxone users. Check the latest studies of Copaxone.

What is Epinephrine?

Epinephrine has active ingredients of epinephrine. It is often used in asthma. eHealthMe is studying from 21,290 Epinephrine users. Check the latest studies of Epinephrine.



On Aug, 11, 2026

19 people who take Copaxone and Epinephrine together, and have interactions are studied.

Copaxone and Epinephrine drug interactions.

What are the common drug interactions of Copaxone and Epinephrine, by gender? *:

female:

  1. Cough
  2. Dyspnoea (difficult or laboured respiration)
  3. Fall
  4. Fatigue (feeling of tiredness)
  5. Injury
  6. Nausea (feeling of having an urge to vomit)
  7. Pain
  8. Pruritus (severe itching of the skin)
  9. Renal failure (kidney dysfunction)
  10. Ankle fracture

male:

  1. Blood glucose increased
  2. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  3. Anxiety
  4. Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
  5. Death
  6. Drug intolerance (drug sensitivity)
  7. Folliculitis (infection of hair root)
  8. Sepsis (a severe blood infection that can lead to organ failure and death)
  9. Stress
  10. Bowel movement irregularity

What are the common drug interactions of Copaxone and Epinephrine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Cough

30-39:

n/a

40-49:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  2. Cough
  3. Ear pruritus (pruritus or itching is ""the unpleasant skin sensation that frequently provokes scratching"" in ear)
  4. Eye pruritus (eye itching)
  5. Fall
  6. Fatigue (feeling of tiredness)
  7. Limb injury
  8. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  9. Oral pruritus (itching in mouth)
  10. Pruritus (severe itching of the skin)

50-59:

  1. Acne cystic (skin problems that cause pimples)
  2. Anxiety
  3. Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
  4. Folliculitis (infection of hair root)
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. Stress

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Ankle fracture
  3. Feeling hot
  4. Foot deformity (functional disability of foot)
  5. Gingival swelling (gums swelling)
  6. Ill-defined disorder
  7. Injection site mass
  8. Malignant melanoma (skin cancer rises from melancytes)
  9. Pain in extremity
  10. Road traffic accident

What are the existing conditions these people have? *

  1. Lipidosis (disorder of lipid metabolism involving abnormal accumulation of lipids in the reticuloendothelial cells): 4 people, 21.05%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 15.79%
  3. Drowsiness: 3 people, 15.79%
  4. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 15.79%
  5. Immunodeficiency Common Variable: 2 people, 10.53%
  6. Wheezing (a high-pitched whistling sound made while you breath): 1 person, 5.26%
  7. Pain: 1 person, 5.26%
  8. Joint Pain: 1 person, 5.26%
  9. Headache (pain in head): 1 person, 5.26%
  10. Gait Disturbance: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Copaxone and Epinephrine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Copaxone and Epinephrine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Copaxone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Epinephrine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Copaxone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Epinephrine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on glatiramer acetate and epinephrine (the active ingredients of Copaxone and Epinephrine, respectively), and Copaxone and Epinephrine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: